{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:13:31Z","timestamp":1793369611879,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Eliciting regulated cell death, like necroptosis, is a potential cancer treatment. However, pathways eliciting necroptosis are poorly understood. It has been reported that prolonged activation of acid-sensing ion channel 1a (ASIC1a) induces necroptosis in mouse neurons. Glioblastoma stem cells (GSCs) also express functional ASIC1a, but whether prolonged activation of ASIC1a induces necroptosis in GSCs is unknown. Here we used a tumorsphere formation assay to show that slight acidosis (pH 6.6) induces necrotic cell death in a manner that was sensitive to the necroptosis inhibitor Nec-1 and to the ASIC1a antagonist PcTx1. In addition, genetic knockout of ASIC1a rendered GSCs resistant to acid-induced reduction in tumorsphere formation, while the ASIC1 agonist MitTx1 reduced tumorsphere formation also at neutral pH. Finally, a 20 amino acid fragment of the ASIC1 C-terminus, thought to interact with the necroptosis kinase RIPK1, was sufficient to reduce the formation of tumorspheres. Meanwhile, the genetic knockout of MLKL, the executive protein in the necroptosis cascade, did not prevent a reduction in tumor sphere formation, suggesting that ASIC1a induced an alternative cell death pathway. These findings demonstrate that ASIC1a is a death receptor on GSCs that induces cell death during prolonged acidosis. We propose that this pathway shapes the evolution of a tumor in its acidic microenvironment and that pharmacological activation of ASIC1a might be a potential new strategy in tumor therapy.<\/jats:p>","DOI":"10.1038\/s41419-022-05139-3","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T18:03:09Z","timestamp":1660327389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Acidosis induces RIPK1-dependent death of glioblastoma stem cells via acid-sensing ion channel 1a"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2925-8438","authenticated-orcid":false,"given":"Jan","family":"Clusmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7189-9346","authenticated-orcid":false,"given":"Klaus-Daniel Cort\u00e9s","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Alejandro Corredor","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0955-8911","authenticated-orcid":false,"given":"Istvan","family":"Katona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Girbes","family":"Minguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Boersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolos-Philippos","family":"Pissas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Vanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7635-9883","authenticated-orcid":false,"given":"Stefan","family":"Gr\u00fcnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"5139_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch\u2019en IL, Korkina O, Teng X, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4:313.","journal-title":"Nat Chem Biol"},{"key":"5139_CR2","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","volume":"137","author":"YS Cho","year":"2009","unstructured":"Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation-driven assembly of the RIP1\u2013RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009;137:1112\u201323.","journal-title":"Cell"},{"key":"5139_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cell.2012.06.019","volume":"150","author":"J Li","year":"2012","unstructured":"Li J, McQuade T, Siemer AB, Napetschnig J, Moriwaki K, Hsiao YS, et al. The RIP1\/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 2012;150:339\u201350.","journal-title":"Cell"},{"key":"5139_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun L, Wang H, Wang Z, He S, Chen S, Liao D, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012;148:213\u201327.","journal-title":"Cell"},{"key":"5139_CR5","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1073\/pnas.1200012109","volume":"109","author":"J Zhao","year":"2012","unstructured":"Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J, et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA. 2012;109:5322\u20137. https:\/\/doi.org\/10.1073\/pnas.1200012109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5139_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1:112\u20139.","journal-title":"Nat Chem Biol"},{"key":"5139_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541.","journal-title":"Cell Death Differ"},{"key":"5139_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ajpath.2019.10.012","volume":"190","author":"MK Khoury","year":"2020","unstructured":"Khoury MK, Gupta K, Franco SR, Liu B. Necroptosis in the pathophysiology of disease. Am J Pathol. 2020;190:272\u201385.","journal-title":"Am J Pathol"},{"key":"5139_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/imr.12583","volume":"280","author":"O Krysko","year":"2017","unstructured":"Krysko O, Aaes TL, Kagan VE, D\u2019Herde K, Bachert C, Leybaert L, et al. Necroptotic cell death in anti-cancer therapy. Immunol Rev. 2017;280:207\u201319.","journal-title":"Immunol Rev"},{"key":"5139_CR10","doi-asserted-by":"publisher","first-page":"e05682","DOI":"10.7554\/eLife.05682","volume":"4","author":"YZ Wang","year":"2015","unstructured":"Wang YZ, Wang JJ, Huang Y, Liu F, Zeng WZ, Li Y, et al. Tissue acidosis induces neuronal necroptosis via ASIC1a channel independent of its ionic conduction. Elife. 2015;4:e05682. https:\/\/doi.org\/10.7554\/eLife.05682.","journal-title":"Elife"},{"key":"5139_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13873-0","volume":"11","author":"J-J Wang","year":"2020","unstructured":"Wang J-J, Liu F, Yang F, Wang Y-Z, Qi X, Li Y, et al. Disruption of auto-inhibition underlies conformational signaling of ASIC1a to induce neuronal necroptosis. Nat Commun. 2020;11:475.","journal-title":"Nat Commun"},{"key":"5139_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/386173a0","volume":"386","author":"R Waldmann","year":"1997","unstructured":"Waldmann R, Champigny G, Bassilana F, Heurteaux C, Lazdunski M. A proton-gated cation channel involved in acid-sensing. Nature 1997;386:173\u20137.","journal-title":"Nature"},{"key":"5139_CR13","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1523\/JNEUROSCI.23-13-05496.2003","volume":"23","author":"JA Wemmie","year":"2003","unstructured":"Wemmie JA, Askwith CC, Lamani E, Cassell MD, Freeman JH Jr., Welsh MJ. Acid-sensing ion channel 1 is localized in brain regions with high synaptic density and contributes to fear conditioning. J Neurosci. 2003;23:5496\u2013502.","journal-title":"J Neurosci"},{"key":"5139_CR14","doi-asserted-by":"publisher","first-page":"41597","DOI":"10.1074\/jbc.M205877200","volume":"277","author":"E Babini","year":"2002","unstructured":"Babini E, Paukert M, Geisler HS, Grunder S. Alternative splicing and interaction with di- and polyvalent cations control the dynamic range of acid-sensing ion channel 1 (ASIC1). J Biol Chem. 2002;277:41597\u2013603.","journal-title":"J Biol Chem"},{"key":"5139_CR15","doi-asserted-by":"publisher","first-page":"25116","DOI":"10.1074\/jbc.M003643200","volume":"275","author":"P Escoubas","year":"2000","unstructured":"Escoubas P, De Weille JR, Lecoq A, Diochot S, Waldmann R, Champigny G, et al. Isolation of a tarantula toxin specific for a class of proton-gated Na+ channels. J Biol Chem. 2000;275:25116\u201321.","journal-title":"J Biol Chem"},{"key":"5139_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cell.2004.08.026","volume":"118","author":"ZG Xiong","year":"2004","unstructured":"Xiong ZG, Zhu XM, Chu XP, Minami M, Hey J, Wei WL, et al. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 2004;118:687\u201398.","journal-title":"Cell"},{"key":"5139_CR17","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1073\/pnas.1614728114","volume":"114","author":"IR Chassagnon","year":"2017","unstructured":"Chassagnon IR, McCarthy CA, Chin YK, Pineda SS, Keramidas A, Mobli M, et al. Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a. Proc Natl Acad Sci USA. 2017;114:3750\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5139_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF01402010","volume":"11","author":"F Pampus","year":"1963","unstructured":"Pampus F. Hydrogen-ion concentration of brain tissue in space-occupying intracranial processes. Acta Neurochir. 1963;11:305\u201318.","journal-title":"Acta Neurochir"},{"key":"5139_CR19","first-page":"1194","volume":"56","author":"LE Gerweck","year":"1996","unstructured":"Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 1996;56:1194\u20138.","journal-title":"Cancer Res"},{"key":"5139_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131:803\u201320.","journal-title":"Acta Neuropathol"},{"key":"5139_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science (New York, NY). 1956;123:309\u201314.","journal-title":"Science (New York, NY)"},{"key":"5139_CR22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756\u201360.","journal-title":"Nature"},{"key":"5139_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012;488:522\u20136.","journal-title":"Nature"},{"key":"5139_CR24","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1101\/gad.261982.115","volume":"29","author":"JD Lathia","year":"2015","unstructured":"Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN. Cancer stem cells in glioblastoma. Genes Dev. 2015;29:1203\u201317.","journal-title":"Genes Dev"},{"key":"5139_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","volume":"9","author":"J Lee","year":"2006","unstructured":"Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer cell. 2006;9:391\u2013403.","journal-title":"Cancer cell"},{"key":"5139_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13666-9","volume":"7","author":"Y Tian","year":"2017","unstructured":"Tian Y, Bresenitz P, Reska A, El Moussaoui L, Beier CP, Grunder S. Glioblastoma cancer stem cell lines express functional acid sensing ion channels ASIC1a and ASIC3. Sci Rep. 2017;7:13674.","journal-title":"Sci Rep"},{"key":"5139_CR27","first-page":"6724","volume":"9","author":"TR D Beier","year":"2016","unstructured":"D Beier TR, Munthe S, Kristensen BW, Beier. CP. Metabolic challenge of proneural glioblastoma cancer stem cell lines does not induce a mesenchymal transformation in vitro. Int J Clin Exp Pathol. 2016;9:6724\u201337. 2016","journal-title":"Int J Clin Exp Pathol"},{"key":"5139_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/bj3150021","volume":"315","author":"EA Slee","year":"1996","unstructured":"Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J. 1996;315:21\u20134.","journal-title":"Biochem J"},{"key":"5139_CR29","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1016\/j.bmcl.2005.04.016","volume":"15","author":"K Dodo","year":"2005","unstructured":"Dodo K, Katoh M, Shimizu T, Takahashi M, Sodeoka M. Inhibition of hydrogen peroxide-induced necrotic cell death with 3-amino-2-indolylmaleimide derivatives. Bioorg Med Chem Lett. 2005;15:3114\u20138.","journal-title":"Bioorg Med Chem Lett"},{"key":"5139_CR30","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1038\/cddis.2012.176","volume":"3","author":"N Takahashi","year":"2012","unstructured":"Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB, et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 2012;3:e437.","journal-title":"Cell Death Dis"},{"key":"5139_CR31","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1021\/ja411006a","volume":"136","author":"R Skouta","year":"2014","unstructured":"Skouta R, Dixon SJ, Wang J, Dunn DE, Orman M, Shimada K, et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc. 2014;136:4551\u20136.","journal-title":"J Am Chem Soc"},{"key":"5139_CR32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.18632\/oncoscience.89","volume":"1","author":"S Melo-Lima","year":"2014","unstructured":"Melo-Lima S, Celeste Lopes M, Mollinedo F. Necroptosis is associated with low procaspase-8 and active RIPK1 and -3 in human glioma cells. Oncoscience 2014;1:649\u201364.","journal-title":"Oncoscience"},{"key":"5139_CR33","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1016\/j.celrep.2019.02.032","volume":"26","author":"I Chefetz","year":"2019","unstructured":"Chefetz I, Grimley E, Yang K, Hong L, Vinogradova EV, Suciu R, et al. A pan-ALDH1A inhibitor induces necroptosis in ovarian cancer stem-like cells. Cell Rep. 2019;26:3061\u201375.e6.","journal-title":"Cell Rep"},{"key":"5139_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acs.chemrestox.2c00044","volume":"35","author":"S Chen","year":"2022","unstructured":"Chen S, Lai W, Li X, Wang H. Necrosulfonamide selectively induces DNA double-strand breaks in acute myeloid leukemia cells. Chem Res Toxicol. 2022;35:387\u2013391. https:\/\/doi.org\/10.1021\/acs.chemrestox.2c00044.","journal-title":"Chem Res Toxicol"},{"key":"5139_CR35","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/sj.emboj.7600177","volume":"23","author":"S Diochot","year":"2004","unstructured":"Diochot S, Baron A, Rash LD, Deval E, Escoubas P, Scarzello S, et al. A new sea anemone peptide, APETx2, inhibits ASIC3, a major acid-sensitive channel in sensory neurons. EMBO J. 2004;23:1516\u201325.","journal-title":"EMBO J"},{"key":"5139_CR36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nature10607","volume":"479","author":"CJ Bohlen","year":"2011","unstructured":"Bohlen CJ, Chesler AT, Sharif-Naeini R, Medzihradszky KF, Zhou S, King D, et al. A heteromeric Texas coral snake toxin targets acid-sensing ion channels to produce pain. Nature 2011;479:410.","journal-title":"Nature"},{"key":"5139_CR37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.addr.2004.12.001","volume":"57","author":"H Brooks","year":"2005","unstructured":"Brooks H, Lebleu B, Viv\u00e8s E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev. 2005;57:559\u201377.","journal-title":"Adv Drug Deliv Rev"},{"key":"5139_CR38","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.cell.2014.01.011","volume":"156","author":"I Baconguis","year":"2014","unstructured":"Baconguis I, Bohlen CJ, Goehring A, Julius D, Gouaux E. X-ray structure of acid-sensing ion channel 1-snake toxin complex reveals open state of a Na(+)-selective channel. Cell 2014;156:717\u201329.","journal-title":"Cell"},{"key":"5139_CR39","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009;137:1100\u201311.","journal-title":"Cell"},{"key":"5139_CR40","first-page":"997","volume":"11","author":"Y Sheng","year":"2021","unstructured":"Sheng Y, Wu B, Leng T, Zhu L, Xiong Z. Acid-sensing ion channel 1 (ASIC1) mediates weak acid-induced migration of human malignant glioma cells. Am J Cancer Res. 2021;11:997\u20131008.","journal-title":"Am J Cancer Res"},{"key":"5139_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bbcan.2019.01.006","volume":"1871","author":"X Qin","year":"2019","unstructured":"Qin X, Ma D, Tan YX, Wang HY, Cai Z. The role of necroptosis in cancer: A double-edged sword? Biochim Biophys Acta Rev Cancer. 2019;1871:259\u201366.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"5139_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1029-8","volume":"18","author":"Y Gong","year":"2019","unstructured":"Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18:100.","journal-title":"Mol Cancer"},{"key":"5139_CR43","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883\u201399.","journal-title":"Cell"},{"key":"5139_CR44","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.aad0395","volume":"350","author":"N Yatim","year":"2015","unstructured":"Yatim N, Jusforgues-Saklani H, Orozco S, Schulz O, Barreira da Silva R, Reis e Sousa C, et al. RIPK1 and NF-kappaB signaling in dying cells determines cross-priming of CD8(+) T cells. Science (New York, NY). 2015;350:328\u201334.","journal-title":"Science (New York, NY)"},{"key":"5139_CR45","doi-asserted-by":"publisher","first-page":"e001369","DOI":"10.1136\/jitc-2020-001369","volume":"8","author":"I Efimova","year":"2020","unstructured":"Efimova I, Catanzaro E, Van der Meeren L, Turubanova VD, Hammad H, Mishchenko TA, et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. 2020;8:e001369. https:\/\/doi.org\/10.1136\/jitc-2020-001369.","journal-title":"J Immunother Cancer"},{"key":"5139_CR46","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","volume":"25","author":"L Voorwerk","year":"2019","unstructured":"Voorwerk L, Slagter M, Horlings HM, Sikorska K, van de Vijver KK, de Maaker M, et al. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. Nat Med. 2019;25:920\u20138.","journal-title":"Nat Med"},{"key":"5139_CR47","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.3390\/cells10082032","volume":"10","author":"H Najem","year":"2021","unstructured":"Najem H, Khasraw M, Heimberger AB. Immune microenvironment landscape in CNS tumors and role in responses to immunotherapy. Cells. 2021;10:2032. https:\/\/doi.org\/10.3390\/cells10082032.","journal-title":"Cells"},{"key":"5139_CR48","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1158\/0008-5472.CAN-08-4079","volume":"69","author":"S Park","year":"2009","unstructured":"Park S, Hatanpaa KJ, Xie Y, Mickey BE, Madden CJ, Raisanen JM, et al. The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Res. 2009;69:2809\u201316.","journal-title":"Cancer Res"},{"key":"5139_CR49","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s11060-020-03473-0","volume":"147","author":"GA Vergara","year":"2020","unstructured":"Vergara GA, Eugenio GC, Malheiros SMF, Victor EDS, Weinlich R. RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping. J Neuro-Oncol. 2020;147:587\u201394.","journal-title":"J Neuro-Oncol"},{"key":"5139_CR50","doi-asserted-by":"publisher","first-page":"821","DOI":"10.21037\/tcr.2019.05.01","volume":"8","author":"Y Dong","year":"2019","unstructured":"Dong Y, Sun Y, Huang Y, Dwarakanath B, Kong L, Lu JJ. Upregulated necroptosis-pathway-associated genes are unfavorable prognostic markers in low-grade glioma and glioblastoma multiforme. Transl Cancer Res. 2019;8:821\u20137.","journal-title":"Transl Cancer Res"},{"key":"5139_CR51","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"W Brennan Cameron","year":"2013","unstructured":"Brennan Cameron W, Verhaak Roel GW, McKenna A, Campos B, Noushmehr H, Salama Sofie R, et al. The somatic genomic landscape of glioblastoma. Cell 2013;155:462\u201377.","journal-title":"Cell"},{"key":"5139_CR52","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-06-4180","volume":"67","author":"D Beier","year":"2007","unstructured":"Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, et al. CD133(+) and CD133(\u2212) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007;67:4010\u20135.","journal-title":"Cancer Res"},{"key":"5139_CR53","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3233\/JAD-161131","volume":"57","author":"EB Gonzales","year":"2017","unstructured":"Gonzales EB, Sumien N. Acidity and acid-sensing ion channels in the normal and Alzheimer\u2019s disease brain. J Alzheimers Dis. 2017;57:1137\u201344.","journal-title":"J Alzheimers Dis"},{"key":"5139_CR54","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/nm1668","volume":"13","author":"MA Friese","year":"2007","unstructured":"Friese MA, Craner MJ, Etzensperger R, Vergo S, Wemmie JA, Welsh MJ, et al. Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system. Nat Med. 2007;13:1483\u20139.","journal-title":"Nat Med"},{"key":"5139_CR55","doi-asserted-by":"publisher","first-page":"730641","DOI":"10.3389\/fncel.2021.730641","volume":"15","author":"D Mango","year":"2021","unstructured":"Mango D, Nistic\u00f2 R. Neurodegenerative disease: what potential therapeutic role of acid-sensing ion channels? Front Cell Neurosci. 2021;15:730641.","journal-title":"Front Cell Neurosci"},{"key":"5139_CR56","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/brain\/aws325","volume":"136","author":"T Arun","year":"2013","unstructured":"Arun T, Tomassini V, Sbardella E, de Ruiter MB, Matthews L, Leite MI, et al. Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride. Brain. 2013;136:106\u201315.","journal-title":"Brain"},{"key":"5139_CR57","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.nbd.2008.05.008","volume":"31","author":"RL Arias","year":"2008","unstructured":"Arias RL, Sung ML, Vasylyev D, Zhang MY, Albinson K, Kubek K, et al. Amiloride is neuroprotective in an MPTP model of Parkinson\u2019s disease. Neurobiol Dis. 2008;31:334\u201341.","journal-title":"Neurobiol Dis"},{"key":"5139_CR58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","volume":"20","author":"J Yuan","year":"2019","unstructured":"Yuan J, Amin P, Ofengeim D. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci. 2019;20:19\u201333.","journal-title":"Nat Rev Neurosci"},{"key":"5139_CR59","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.celrep.2015.02.051","volume":"10","author":"D Ofengeim","year":"2015","unstructured":"Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, DeWitt JP, et al. Activation of necroptosis in multiple sclerosis. Cell Rep. 2015;10:1836\u201349.","journal-title":"Cell Rep"},{"key":"5139_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.15252\/emmm.201606566","volume":"9","author":"SH Yang","year":"2017","unstructured":"Yang SH, Lee DK, Shin J, Lee S, Baek S, Kim J, et al. Nec-1 alleviates cognitive impairment with reduction of A\u03b2 and tau abnormalities in APP\/PS1 mice. EMBO Mol Med. 2017;9:61\u201377.","journal-title":"EMBO Mol Med"},{"key":"5139_CR61","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nn.4608","volume":"20","author":"A Caccamo","year":"2017","unstructured":"Caccamo A, Branca C, Piras IS, Ferreira E, Huentelman MJ, Liang WS, et al. Necroptosis activation in Alzheimer\u2019s disease. Nat Neurosci. 2017;20:1236\u201346.","journal-title":"Nat Neurosci"},{"key":"5139_CR62","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41418-019-0408-4","volume":"27","author":"M O\u00f1ate","year":"2020","unstructured":"O\u00f1ate M, Catenaccio A, Salvadores N, Saquel C, Martinez A, Moreno-Gonzalez I, et al. The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease. Cell Death Differ. 2020;27:1169\u201385.","journal-title":"Cell Death Differ"},{"key":"5139_CR63","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.4103\/1673-5374.160108","volume":"10","author":"JR Wu","year":"2015","unstructured":"Wu JR, Wang J, Zhou SK, Yang L, Yin JL, Cao JP, et al. Necrostatin-1 protection of dopaminergic neurons. Neural Regen Res. 2015;10:1120\u20134.","journal-title":"Neural Regen Res"},{"key":"5139_CR64","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.2174\/1570159X16666180302115544","volume":"16","author":"E Sekerdag","year":"2018","unstructured":"Sekerdag E, Solaroglu I, Gursoy-Ozdemir Y. Cell death mechanisms in stroke and novel molecular and cellular treatment options. Curr Neuropharmacol. 2018;16:1396\u2013415.","journal-title":"Curr Neuropharmacol"},{"key":"5139_CR65","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11064-014-1510-0","volume":"40","author":"X Su","year":"2015","unstructured":"Su X, Wang H, Kang D, Zhu J, Sun Q, Li T, et al. Necrostatin-1 ameliorates intracerebral hemorrhage-induced brain injury in mice through inhibiting RIP1\/RIP3 pathway. Neurochem Res. 2015;40:643\u201350.","journal-title":"Neurochem Res"},{"key":"5139_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33282-5","volume":"8","author":"CP Beier","year":"2018","unstructured":"Beier CP, Rasmussen T, Dahlrot RH, Tenstad HB, Aar\u00f8 JS, S\u00f8rensen MF, et al. Aberrant neuronal differentiation is common in glioma but is associated neither with epileptic seizures nor with better survival. Sci Rep. 2018;8:14965.","journal-title":"Sci Rep"},{"key":"5139_CR67","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s42003-019-0393-7","volume":"2","author":"J Michl","year":"2019","unstructured":"Michl J, Park KC, Swietach P. Evidence-based guidelines for controlling pH in mammalian live-cell culture systems. Commun Biol. 2019;2:144.","journal-title":"Commun Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05139-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05139-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05139-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:13:34Z","timestamp":1669302814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05139-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":67,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["5139"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05139-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"15 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"702"}}